Published in Vaccine Weekly, August 24th, 2011
"In a recent work, Fytili et al. (2008) studied the cross reactive potential of HCV specific CD8+...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.